What is ENZ's gross margin?

Enzo Biochem (ENZ) has a gross margin of 39% and a net margin of -44%.

What is ENZ's P/E ratio?

Track Enzo Biochem (ENZ) P/E ratio, ROE, and valuation metrics over time.

Where can I see ENZ's full financials?

See Enzo Biochem (ENZ) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Enzo Biochem (ENZ) Financials — Revenue, Earnings, Cash Flow

Also trades as: ENZB (OTC) · $vol 0M

$0.31

Last traded 2025-05-15 — delisted

NYSE · Healthcare · Medical - Diagnostics & Research · $16.4M mcap · 36M float · 0.957% daily turnover · Short 27% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$27M

Revenue

+482.0% YoY

$-21M

Net Income

-147.1% YoY

$-16M

Free Cash Flow

+62.2% YoY

38.8%

Gross Margin

-52.9%

Op. Margin

-43.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-37.5%

ROA-26.9%

ROIC-87.3%

Valuation

P/E-0.6

P/B0.3

EV/EBITDA1.3

Leverage

Debt/Equity0.07

Current Ratio2.84

Interest Cov.-53.8x

Quality Scores

Piotroski F3/9

Altman Z-5.44

Beneish M-3.17